When you start your Fasenra® treatment, your healthcare professional may give you a folder containing the following materials to support you during your treatment:
-1.png)
When you start your Fasenra® (benralizumab) treatment, your healthcare professional may give you a folder containing the following materials to support you during your treatment:
If your first language is not English,
we offer a patient booklet with
all the information you may
need in 12 languages!
GB-69752 I DOP: September 2025
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine.
This is a non-promotional website developed and funded by AstraZeneca.
This site is intended to complement, not replace the 'Instructions for Use' and 'Patient Information Leaflet' (found in your medicine pack). Refer to these materials for additional important information.
If you have any questions or concerns about your treatment, you should always talk to your healthcare team.
Download
